Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lisa D.S. Johnson"'
Autor:
Owen A. O'Connor, Yaping Shou, Kathleen Roberge, Anca Milea, Eric L. Sievers, Robert A. Uger, Penka S. Petrova, Tina Catalano, Lisa D.S. Johnson, Oleg E. Akilov, Christiane Querfeld, Kerry J. Savage, Jasmine Zain, Matthew G. Mei, Steven M. Horwitz, James M. Foran, Anjali S. Advani, Mary-Elizabeth M. Percival, Diego Villa, Mark D. Minden, Ahmed Sawas, Ian W. Flinn, Robert W. Chen, Alexander M. Lesokhin, Michael B. Maris, Stephen M. Ansell
Study Schema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::281c50bb0e69ede50363e21f4afa6737
https://doi.org/10.1158/1078-0432.22482851.v1
https://doi.org/10.1158/1078-0432.22482851.v1
Autor:
Owen A. O'Connor, Yaping Shou, Kathleen Roberge, Anca Milea, Eric L. Sievers, Robert A. Uger, Penka S. Petrova, Tina Catalano, Lisa D.S. Johnson, Oleg E. Akilov, Christiane Querfeld, Kerry J. Savage, Jasmine Zain, Matthew G. Mei, Steven M. Horwitz, James M. Foran, Anjali S. Advani, Mary-Elizabeth M. Percival, Diego Villa, Mark D. Minden, Ahmed Sawas, Ian W. Flinn, Robert W. Chen, Alexander M. Lesokhin, Michael B. Maris, Stephen M. Ansell
Purpose:TTI-621 (SIRPα-IgG1 Fc) is a novel checkpoint inhibitor that activates antitumor activity by blocking the CD47 “don't eat me” signal. This first-in-human phase I study (NCT02663518) evaluated the safety and activity of TTI-621 in relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6229d70998f979096284ba3849db926
https://doi.org/10.1158/1078-0432.c.6531017
https://doi.org/10.1158/1078-0432.c.6531017
Autor:
Hussein Al-Sudani, Ying Ni, Philip Jones, Huseyin Karakilic, Lei Cui, Lisa D.S. Johnson, Peter G. Rose, Alexander Olawaiye, Robert P. Edwards, Robert A. Uger, Gloria Lin, Haider Mahdi
Publikováno v:
SSRN Electronic Journal.